Lantheus Adds Proxy Disclosures on Curium Merger Valuation, Morgan Stanley Conflicts
Article excerpt
Highlighted: the sentence this signal was extracted from
Lantheus Holdings (Nasdaq: LNTH) filed an 8-K on Oct. 2, 2026, providing supplemental disclosures to its definitive proxy statement for the pending Curium merger, adding detailed valuation ranges used by Morgan Stanley and clarifying a prior advisory relationship with CapVest. The company said it made the disclosures solely to avoid the costs and uncertainties of litigation, and denied that the original proxy statement was deficient or that the new information is material or required. The merger terms, deal structure and the Oct. 14, 2026 special meeting timeline are unchanged. The supplemental disclosures fill in specifics behind Morgan Stanley's fairness opinion, including: On the conflict-of-interest question, the company disclosed that in the two years before its opinion date, Morgan Stanley and its affiliates received no fees from Curium for financial advisory or financial services. However, Morgan Stanley received fees of between $5 million and $10 million from the company, and a separate $5 million to $10 million from certain affiliates of CapVest, in each case over the prior two years. Morgan Stanley also held an aggregate interest of between 2% and 3% in Lantheus common stock as of Aug. 3, 2026. The supplemental filing also states that no proposals or indications of interest from Parent discussed retention of the company's executives or their purchase of Parent...
Keep reading with a free account
The rest of this article, and every signal for Morgan Stanley, is in your free account.